Lexaria Bioscience widens scope of pharmaceutical subsidiary in bid to develop treatment for coronavirus

Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP) told investors Monday that it has broadened the scope of its pharmaceutical subsidiary in a bid to help assist in the global fight against coronavirus. The company’s subsidiary Lexaria Pharmaceutical Corp will look at how the parent company’s ...

from Latest News on One News Page - Top Headlines and News Videos https://ift.tt/2vIDN3n

Share on Google Plus

About JULIA

Oddepia Is Our Company And Our Mission To Publish Latest News As Soon As Possible. Please Like And Share If You Like.